Journal of Business Ethics

, Volume 79, Issue 1–2, pp 21–28 | Cite as

Truthfulness and Business

  • Lubomira Radoilska


According to a common assumption, truthfulness cannot have an intrinsic value in business. Instead, it is considered only instrumentally valuable for business, because it contributes to successful trust-building. Some authors deny truthfulness even this limited role by claiming that truth-telling is not an essential part of business, which is a sui generis practice like poker. In this article, I argue that truthfulness has indeed an intrinsic value in business and identify the conceptual confusions underlying the opposite view. My account of truthfulness as a virtue shows that truthfulness is both valuable for its own sake and instrumental to further valuable goals. It helps pinpoint the implicit contradiction in claiming that truthfulness has an instrumental value only. I then challenge the reasons for considering business exempt from the constraints of truthfulness and elaborate on the analogy between game and business, which in fact supports instead of undermining my claim that business is a truthful practice. Finally, I illustrate my argument with a case study of the current crisis of trust faced by the pharmaceutical industry.


business game pharmaceuticals trust truthfulness value virtue 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aristotle: 1996, Metaphysics, Loeb Classical Library, vol. 17, 18 (Harvard University Press, Cambridge, MA)Google Scholar
  2. Aristotle: 1982, Nicomachean Ethics, Loeb Classical Library, vol. 19 (Harvard University Press, Cambridge, MA)Google Scholar
  3. Angell M. (2005), The Truth about the Drug Companies: How They Deceive Us and What to Do about It. Random House Trade Paperback, NYGoogle Scholar
  4. Arrow K. (1984), The Economics of Information. The Belknap Press, Cambridge, MAGoogle Scholar
  5. Bok S. (1978), Lying: Moral Choice in Public and Private Life. The Harvester Press, HassocksGoogle Scholar
  6. Bok S. (1984), Secrets: On the Ethics of Concealment and Revelation. Oxford University Press, OxfordGoogle Scholar
  7. Carr A.: 1968, ‹Is Business Bluffing Ethical?’, Harvard Business Review, Jan–Feb, pp. 143–153Google Scholar
  8. Dewey J., Tufts J. (1908), Ethics. Holt, Rinehart and Winston, NYGoogle Scholar
  9. Duska R. (2000), “Business Ethics: Oxymoron or Good Business?”. Business Ethics Quarterly 10(1), 111–129CrossRefGoogle Scholar
  10. Frantz S. (2005), “Vioxx Fears Prompt Call for User fee Evaluation”. Drug Discovery 4, 179CrossRefGoogle Scholar
  11. Gambetta D. (1988), “Mafia: the Price of Distrust”. In: D. Gambetta (ed), Trust: Making and Breaking Cooperative Relations. Balckwell, Oxford. pp. 158–175Google Scholar
  12. Gevertz N., Amado R. (2004), “Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property”. Journal of Business Ethics 55, 295–308CrossRefGoogle Scholar
  13. Hausman C. (2000), Lies We Live By: Defeating Double-Talk and Deception in Advertising, and the Media. Routledge, NYGoogle Scholar
  14. Hawthorne F. (2003), The Merck Druggernaut. Wiley, ChichesterGoogle Scholar
  15. Kaiser HealthPoll Report: 2005, (Retrieved August 8, 2006) Scholar
  16. Keep W. (2003), “Adam Smith’s Imperfect Hand: Motivations to Mislead”. Business Ethics: A European Review 12(4), 343–353CrossRefGoogle Scholar
  17. Koehn D. (1997), “Business and Game-Playing: The False Analogy”. Journal of Business Ethics 16, 1447–1452CrossRefGoogle Scholar
  18. Korsgaard C. (1983), “Two Distinctions in Goodness”, Philosophical Review 91, 27–49Google Scholar
  19. Kramer R., Tylor T. (eds) (1996), Trust in Organisations. SAGE, LondonGoogle Scholar
  20. Institute of Medicine: Committee on Implications of For-Profit Enterprise in Health Care: (1986), For-Profit Enterprise in Health Care. National Academy Press, WashingtonGoogle Scholar
  21. Lanjouw J. (2003), “Intellectual Property and the Availability of Pharmaceuticals in Poor Countries”. Innovation Policy and the Economy 3, 91–129Google Scholar
  22. Luhman N. (1979), Trust & Power. Wiley, ChichesterGoogle Scholar
  23. MacIntyre A. (1985), After Virtue: A Study on Moral Theory, 2nd ed. Duckworth, LondonGoogle Scholar
  24. MacIntyre, A.: 1995, ‹Truthfulness, Lies, and Moral Philosophers: What Can We Learn from Mill and Kant?’, in Tanner Lectures on Human Values, vol. 16 (University of Utah Press, Salt Lake City)Google Scholar
  25. Moynihan R., Heath I., Henry D. (2002), “Selling Sickness: the Pharmaceutical Industry and Disease Mongering”. British Medical Journal 324, 886–891CrossRefGoogle Scholar
  26. Radoilska, L. and Scott, D.: 2005, ‹Trust in the Pharmaceutical Industry: A Philosophical Perspective’, (Retreived August 8, 2006). %20Industry.pdf Google Scholar
  27. Rooner, L.: 2005, ‹Novartis Chief Admits Pharmaceutical Industry Has Lost Public Trust’, The Ethical Corporation, 25.01.2005Google Scholar
  28. Salek S, Edgar A. (eds) (2002), Pharmaceutical Ethics. Wiley, ChichesterGoogle Scholar
  29. Santoro M., Gorrie T. (2005) Ethics and the Pharmaceutical Industry. Cambridge University Press, CambridgeGoogle Scholar
  30. Serban G. (2001), Lying: Man’s Second Nature. Praeger, Wesport, ConnGoogle Scholar
  31. Smith R. (2003), “Medical Journals and Pharmaceutical Companies: Uneasy Bedfellows”, British Medical Journal 326, 1202–1205CrossRefGoogle Scholar
  32. Stancich, R.: 2003, ‹The Pharmaceutical Industry: A Cross-Section of CR Practice’, The Ethical Corporation, 17.11.2003Google Scholar
  33. Tian K., Keep B. (2002), Customer Fraud and Business Responses. Greenwood Publishing, Westport, CTGoogle Scholar
  34. Williams B. (1981), “Practical Necessity” in B. Williams, Moral Luck. Cambridge University Press, Cambridge, pp. 124–131Google Scholar
  35. Williams B. (1995), “Moral Incapacity” in B. Williams, Making Sense of Humanity and Other Philosophical Papers. Cambridge University Press, Cambridge, pp. 46–55Google Scholar
  36. Williams B. (2002), Truth and Truthfulness: An Essay in Genealogy. Princeton University Press, PrincetonGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  1. 1.Cambridge UniversityCambridgeUK

Personalised recommendations